Research Interest: Aspect of biochemistry,
molecular biology, endocrinology, metabolism, nutrition, pharmacology, and
toxicology. Dr. Yamaguchi has an interesting for cell signaling mechanism, bone
biology, nutritional factor and osteoporosis prevention, diabetes and diabetic
osteoporosis, cancer biology, and cancer bone metastasis. Dr. Yamaguchi
discovered two novel proteins and genes; cell signaling suppressor protein
(named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene
promoter region-related protein; 2001) in mammalian cells. Dr. Yamaguchi
generated regucalcin transgenic rats, which were registered as international
patents (USA, EU, Japan, and Korea), and this animal was found to induce
osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential
role of regucalcin as a key suppressor protein in carcinogenesis. Currently, the research of regucalcin is
focused as a scientific topic
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."